United States Biotechnology & Medical Research

Karuna Therapeutics Inc (KRTX)

Track

Ticker: KRTX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Karuna Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Brannan Stephen K.
Chief Medical Officer
3 sales — total 3,183,433 USD
Planned sale 8 Mar 2024
Value US$223,184.96 | Price 161.01 | Shares 58,644
Planned sale 8 Mar 2024
Value US$4,091,945.58 | Price 418.43 | Shares 89,800
Proposed sale 8 Mar 2024
Value US$1,591,720.00 | Price 318.34 | Shares 5,000
Planned sale 8 Feb 2024
Value US$647,457.57 | Price 91.15 | Shares 29,347
Planned sale 8 Feb 2024
Value US$126,897.53 | Price 443.26 | Shares 36,523
Proposed sale 8 Feb 2024
Value US$1,580,662.00 | Price 316.13 | Shares 5,000
Planned sale 8 Jan 2024
Value US$4,752,150.00 | Price 316.81 | Shares 15,000
Proposed sale 8 Jan 2024
Value US$4,752,164.00 | Price 316.81 | Shares 15,000
Proposed sale 27 Dec 2023
Value US$17,962,226.00 | Price 317.18 | Shares 56,631
Planned sale 8 Dec 2023
Value US$20,213.82 | Price 204.18 | Shares 99
Planned sale 8 Dec 2023
Value US$458,753.80 | Price 203.80 | Shares 2,251
Planned sale 8 Dec 2023
Value US$804,675.06 | Price 202.74 | Shares 3,969
Planned sale 8 Dec 2023
Value US$426,860.68 | Price 201.73 | Shares 2,116
Planned sale 8 Dec 2023
Value US$313,172.15 | Price 200.11 | Shares 1,565
Proposed sale 8 Dec 2023
Value US$2,023,671.00 | Price 202.37 | Shares 10,000
Proposed sale 6 Dec 2023
Value US$16,053,295.00 | Price 210.24 | Shares 76,357
Proposed sale 28 Nov 2023
Value US$1,121,923.00 | Price 186.99 | Shares 6,000
Proposed sale 21 Nov 2023
Value US$1,114,939.62 | Price 185.82 | Shares 6,000
Planned sale 8 Nov 2023
Value US$404,279.60 | Price 180.08 | Shares 2,245
Planned sale 8 Nov 2023
Value US$144,551.20 | Price 178.90 | Shares 808
Planned sale 8 Nov 2023
Value US$46,942.10 | Price 177.14 | Shares 265
Planned sale 8 Nov 2023
Value US$70,451.69 | Price 175.69 | Shares 401
Planned sale 8 Nov 2023
Value US$223,034.91 | Price 174.11 | Shares 1,281
Proposed sale 8 Nov 2023
Value US$889,262.00 | Price 177.85 | Shares 5,000
Proposed sale 9 Oct 2023
Value US$866,228.00 | Price 173.25 | Shares 5,000
Planned sale 9 Oct 2023
Value US$303,054.88 | Price 173.77 | Shares 1,744
Planned sale 9 Oct 2023
Value US$563,157.76 | Price 172.96 | Shares 3,256
Planned sale 8 Sep 2023
Value US$11,136.00 | Price 185.60 | Shares 60
Planned sale 8 Sep 2023
Value US$168,007.24 | Price 185.03 | Shares 908
Planned sale 8 Sep 2023
Value US$507,462.28 | Price 184.13 | Shares 2,756
Planned sale 8 Sep 2023
Value US$233,597.32 | Price 183.07 | Shares 1,276
Proposed sale 8 Sep 2023
Value US$920,207.00 | Price 184.04 | Shares 5,000
Planned sale 1 Sep 2023
Value US$75,403.02 | Price 188.98 | Shares 399
Planned sale 1 Sep 2023
Value US$1,586,387.82 | Price 188.34 | Shares 8,423
Planned sale 1 Sep 2023
Value US$821,509.62 | Price 187.26 | Shares 4,387
Planned sale 1 Sep 2023
Value US$111,804.00 | Price 186.34 | Shares 600
Planned sale 22 Aug 2023
Value US$10,596.00 | Price 176.60 | Shares 60
Planned sale 22 Aug 2023
Value US$88,672.95 | Price 175.59 | Shares 505
Planned sale 22 Aug 2023
Value US$149,522.40 | Price 174.88 | Shares 855
Planned sale 22 Aug 2023
Value US$13,891.20 | Price 173.64 | Shares 80
Proposed sale 22 Aug 2023
Value US$262,679.00 | Price 175.12 | Shares 1,500
Planned sale 8 Aug 2023
Value US$226,875.00 | Price 181.50 | Shares 1,250
Planned sale 8 Aug 2023
Value US$245,160.15 | Price 180.93 | Shares 1,355
Planned sale 8 Aug 2023
Value US$429,974.35 | Price 179.53 | Shares 2,395
Proposed sale 8 Aug 2023
Value US$902,003.00 | Price 180.40 | Shares 5,000
Planned sale 1 Aug 2023
Value US$119,046.00 | Price 198.41 | Shares 600
Planned sale 1 Aug 2023
Value US$79,064.00 | Price 197.66 | Shares 400
Planned sale 1 Aug 2023
Value US$611,394.90 | Price 196.59 | Shares 3,110
Planned sale 1 Aug 2023
Value US$1,232,538.61 | Price 195.61 | Shares 6,301
Planned sale 1 Aug 2023
Value US$662,057.22 | Price 194.78 | Shares 3,399
Planned sale 3 Jul 2023
Value US$86,412.00 | Price 216.03 | Shares 400
Planned sale 3 Jul 2023
Value US$129,240.00 | Price 215.40 | Shares 600
Proposed sale 3 Jul 2023
Value US$215,651.00 | Price 215.65 | Shares 1,000
Planned sale 3 Jul 2023
Value US$524,728.38 | Price 217.82 | Shares 2,409
Planned sale 3 Jul 2023
Value US$693,912.78 | Price 216.78 | Shares 3,201
Planned sale 3 Jul 2023
Value US$1,719,939.06 | Price 215.91 | Shares 7,966
Planned sale 3 Jul 2023
Value US$50,218.74 | Price 214.61 | Shares 234
Proposed sale 3 Jul 2023
Value US$8,966,155.32 | Price 216.42 | Shares 41,429
Planned sale 23 May 2023
Value US$176,677.26 | Price 225.93 | Shares 782
Planned sale 23 May 2023
Value US$230,144.18 | Price 225.19 | Shares 1,022
Planned sale 23 May 2023
Value US$239,883.30 | Price 224.19 | Shares 1,070
Planned sale 23 May 2023
Value US$738,601.89 | Price 223.21 | Shares 3,309
Planned sale 23 May 2023
Value US$465,148.32 | Price 222.24 | Shares 2,093
Planned sale 23 May 2023
Value US$160,206.72 | Price 221.28 | Shares 724
Proposed sale 23 May 2023
Value US$2,010,663.00 | Price 223.41 | Shares 9,000
Planned sale 20 Apr 2023
Value US$3,001,950.00 | Price 200.13 | Shares 15,000
Planned sale 18 Apr 2023
Value US$6,004,800.00 | Price 200.16 | Shares 30,000
Proposed sale 18 Apr 2023
Value US$8,894,250.00 | Price 197.65 | Shares 45,000
Planned sale 10 Apr 2023
Value US$884,400.00 | Price 176.88 | Shares 5,000
Planned sale 3 Apr 2023
Value US$181,020.00 | Price 181.02 | Shares 1,000
Planned sale 9 Mar 2023
Value US$947,550.00 | Price 189.51 | Shares 5,000
Planned sale 21 Feb 2023
Value US$1,140,060.00 | Price 190.01 | Shares 6,000
Planned sale 9 Feb 2023
Value US$961,850.00 | Price 192.37 | Shares 5,000
Planned sale 18 Jan 2023
Value US$40,028.00 | Price 200.14 | Shares 200
Planned sale 17 Jan 2023
Value US$164,551.97 | Price 201.41 | Shares 817
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-11 2024-03-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
58,644 +4.5%
161.01
US$223,185 		58,644 +4.5% 161.01 US$223,185
2024-03-11 2024-03-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
89,800 -42.5%
418.43
US$4,091,946 		89,800 -42.5% 418.43 US$4,091,946
2024-03-08 2024-03-08 PrS Proposed sale
Brannan Stephen K.

Officer

Officer
44,308
223.43
US$1,711,287 		44,308 223.43 US$1,711,287
2024-02-12 2024-02-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
818 -1.9%
316.56
US$258,946 		818 -1.9% 316.56 US$258,946
2024-02-12 2024-02-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
4,182 -9.1%
316.05
US$1,321,721 		4,182 -9.1% 316.05 US$1,321,721
2024-02-08 2024-02-08 PrS Proposed sale
Brannan Stephen K.

Officer

Officer
5,000
316.13
US$1,580,662 		5,000 316.13 US$1,580,662
2024-01-09 2024-01-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
15,000 -28.0%
316.81
US$4,752,150 		15,000 -28.0% 316.81 US$4,752,150
2024-01-08 2024-01-08 PrS Proposed sale
Brannan Stephen K.

Officer

Officer
15,000
316.81
US$4,752,164 		15,000 316.81 US$4,752,164
2023-12-27 2023-12-27 PrS Proposed sale
3.6
Ignelzi Troy A.

Former Affiliate
56,631
317.18
US$17,962,226 		56,631 317.18 US$17,962,226
2023-12-12 2023-12-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
99 -0.3%
204.18
US$20,214 		99 -0.3% 204.18 US$20,214
2023-12-12 2023-12-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
2,251 -5.8%
203.80
US$458,754 		2,251 -5.8% 203.80 US$458,754
2023-12-12 2023-12-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
3,969 -9.3%
202.74
US$804,675 		3,969 -9.3% 202.74 US$804,675
2023-12-12 2023-12-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
2,116 -4.7%
201.73
US$426,861 		2,116 -4.7% 201.73 US$426,861
2023-12-12 2023-12-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
1,565 -3.4%
200.11
US$313,172 		1,565 -3.4% 200.11 US$313,172
2023-12-08 2023-12-08 PrS Proposed sale
Brannan Stephen K.

Officer

Officer
10,000
202.37
US$2,023,671 		10,000 202.37 US$2,023,671
2023-12-06 2023-12-06 PrS Proposed sale
3.6
Ignelzi Troy A.

Former Affiliate
76,357
210.24
US$16,053,295 		76,357 210.24 US$16,053,295
2023-11-28 2023-11-28 PrS Proposed sale
3.6
Ignelzi Troy A.

Former Affiliate
6,000
186.99
US$1,121,923 		6,000 186.99 US$1,121,923
2023-11-21 2023-11-21 PrS Proposed sale
3.6
Ignelzi Troy A.

Former Affiliate
6,000
185.82
US$1,114,940 		6,000 185.82 US$1,114,940
2023-11-13 2023-11-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
2,245 -6.3%
180.08
US$404,280 		2,245 -6.3% 180.08 US$404,280
2023-11-13 2023-11-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
808 -2.2%
178.90
US$144,551 		808 -2.2% 178.90 US$144,551
2023-11-13 2023-11-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
265 -0.7%
177.14
US$46,942 		265 -0.7% 177.14 US$46,942
2023-11-13 2023-11-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
401 -1.1%
175.69
US$70,452 		401 -1.1% 175.69 US$70,452
2023-11-13 2023-11-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
1,281 -3.3%
174.11
US$223,035 		1,281 -3.3% 174.11 US$223,035
2023-11-08 2023-11-08 PrS Proposed sale
Brannan Stephen K.

Officer

Officer
5,000
177.85
US$889,262 		5,000 177.85 US$889,262
2023-10-10 2023-10-09 PrS Proposed sale
Brannan Stephen K.

Officer

Officer
5,000
173.25
US$866,228 		5,000 173.25 US$866,228
2023-10-10 2023-10-09 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
1,744 -5.3%
173.77
US$303,055 		1,744 -5.3% 173.77 US$303,055
2023-10-10 2023-10-09 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
3,256 -9.0%
172.96
US$563,158 		3,256 -9.0% 172.96 US$563,158
2023-09-11 2023-09-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
60 -0.2%
185.60
US$11,136 		60 -0.2% 185.60 US$11,136
2023-09-11 2023-09-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
908 -3.1%
185.03
US$168,007 		908 -3.1% 185.03 US$168,007
2023-09-11 2023-09-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
2,756 -8.5%
184.13
US$507,462 		2,756 -8.5% 184.13 US$507,462
2023-09-11 2023-09-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
1,276 -3.8%
183.07
US$233,597 		1,276 -3.8% 183.07 US$233,597
2023-09-08 2023-09-08 PrS Proposed sale
Brannan Stephen K.

Officer

Officer
5,000
184.04
US$920,207 		5,000 184.04 US$920,207
2023-09-05 2023-09-01 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
399 -28.7%
188.98
US$75,403 		399 -28.7% 188.98 US$75,403
2023-09-05 2023-09-01 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
8,423 -85.8%
188.34
US$1,586,388 		8,423 -85.8% 188.34 US$1,586,388
2023-09-05 2023-09-01 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
4,387 -30.9%
187.26
US$821,510 		4,387 -30.9% 187.26 US$821,510
2023-09-05 2023-09-01 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
600 -4.1%
186.34
US$111,804 		600 -4.1% 186.34 US$111,804
2023-08-24 2023-08-22 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
60 -0.2%
176.60
US$10,596 		60 -0.2% 176.60 US$10,596
2023-08-24 2023-08-22 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
505 -1.6%
175.59
US$88,673 		505 -1.6% 175.59 US$88,673
2023-08-24 2023-08-22 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
855 -2.7%
174.88
US$149,522 		855 -2.7% 174.88 US$149,522
2023-08-24 2023-08-22 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
80 -0.3%
173.64
US$13,891 		80 -0.3% 173.64 US$13,891
2023-08-22 2023-08-22 PrS Proposed sale
3.6
Ignelzi Troy A.

Officer

Officer
1,500
175.12
US$262,679 		1,500 175.12 US$262,679
2023-08-10 2023-08-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
1,250 -4.6%
181.50
US$226,875 		1,250 -4.6% 181.50 US$226,875
2023-08-10 2023-08-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
1,355 -4.7%
180.93
US$245,160 		1,355 -4.7% 180.93 US$245,160
2023-08-10 2023-08-08 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
2,395 -7.7%
179.53
US$429,974 		2,395 -7.7% 179.53 US$429,974
2023-08-08 2023-08-08 PrS Proposed sale
Brannan Stephen K.

Officer

Officer
5,000
180.40
US$902,003 		5,000 180.40 US$902,003
2023-08-02 2023-08-01 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
600 -37.7%
198.41
US$119,046 		600 -37.7% 198.41 US$119,046
2023-08-02 2023-08-01 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
400 -20.1%
197.66
US$79,064 		400 -20.1% 197.66 US$79,064
2023-08-02 2023-08-01 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
3,110 -61.0%
196.59
US$611,395 		3,110 -61.0% 196.59 US$611,395
2023-08-02 2023-08-01 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
6,301 -55.3%
195.61
US$1,232,539 		6,301 -55.3% 195.61 US$1,232,539
2023-08-02 2023-08-01 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
3,399 -23.0%
194.78
US$662,057 		3,399 -23.0% 194.78 US$662,057
2023-07-05 2023-07-03 PlS Planned sale
0.9
OLSON LAURIE J
Non-Executive Director
400 -28.8%
216.03
US$86,412 		400 -28.8% 216.03 US$86,412
2023-07-05 2023-07-03 PlS Planned sale
0.9
OLSON LAURIE J
Non-Executive Director
600 -30.2%
215.40
US$129,240 		600 -30.2% 215.40 US$129,240
2023-07-05 2023-07-03 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
2,409 -70.9%
217.82
US$524,728 		2,409 -70.9% 217.82 US$524,728
2023-07-05 2023-07-03 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
3,201 -48.5%
216.78
US$693,913 		3,201 -48.5% 216.78 US$693,913
2023-07-05 2023-07-03 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
7,966 -54.7%
215.91
US$1,719,939 		7,966 -54.7% 215.91 US$1,719,939
2023-07-05 2023-07-03 PlS Planned sale
1.5
JONAS JEFFREY M
Non-Executive Director
234 -1.6%
214.61
US$50,219 		234 -1.6% 214.61 US$50,219
2023-07-03 2023-07-03 PrS Proposed sale
0.9
OLSON LAURIE J

Director

Non-Executive Director
1,000
215.65
US$215,651 		1,000 215.65 US$215,651
2023-07-03 2023-07-03 PrS Proposed sale
1.5
JONAS JEFFREY M

Director

Non-Executive Director
41,429
216.42
US$8,966,155 		41,429 216.42 US$8,966,155
2023-05-25 2023-05-23 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
782 -2.5%
225.93
US$176,677 		782 -2.5% 225.93 US$176,677
2023-05-25 2023-05-23 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
1,022 -3.2%
225.19
US$230,144 		1,022 -3.2% 225.19 US$230,144
2023-05-25 2023-05-23 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
1,070 -3.2%
224.19
US$239,883 		1,070 -3.2% 224.19 US$239,883
2023-05-25 2023-05-23 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
3,309 -9.0%
223.21
US$738,602 		3,309 -9.0% 223.21 US$738,602
2023-05-25 2023-05-23 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
2,093 -5.4%
222.24
US$465,148 		2,093 -5.4% 222.24 US$465,148
2023-05-25 2023-05-23 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
724 -1.8%
221.28
US$160,207 		724 -1.8% 221.28 US$160,207
2023-05-23 2023-05-23 PrS Proposed sale
3.6
Ignelzi Troy A.

Officer

Officer
9,000
223.41
US$2,010,663 		9,000 223.41 US$2,010,663
2023-04-20 2023-04-20 PlS Planned sale
Miller Andrew Craig

Chief Operating Officer

Officer
15,000 -38.1%
200.13
US$3,001,950 		15,000 -38.1% 200.13 US$3,001,950
2023-04-20 2023-04-18 PlS Planned sale
Miller Andrew Craig

Chief Operating Officer

Officer
30,000 -49.3%
200.16
US$6,004,800 		30,000 -49.3% 200.16 US$6,004,800
2023-04-18 2023-04-18 PrS Proposed sale
Andrew Miller

Affiliate
45,000
197.65
US$8,894,250 		45,000 197.65 US$8,894,250
2023-04-12 2023-04-10 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
5,000 -17.5%
176.88
US$884,400 		5,000 -17.5% 176.88 US$884,400
2023-04-05 2023-04-03 PlS Planned sale
0.9
OLSON LAURIE J
Non-Executive Director
1,000 -100.0%
181.02
US$181,020 		1,000 -100.0% 181.02 US$181,020
2023-03-09 2023-03-09 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
5,000 -17.5%
189.51
US$947,550 		5,000 -17.5% 189.51 US$947,550
2023-02-23 2023-02-21 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
6,000 -16.4%
190.01
US$1,140,060 		6,000 -16.4% 190.01 US$1,140,060
2023-02-13 2023-02-09 PlS Planned sale
Brannan Stephen K.

Chief Medical Officer

Officer
5,000 -25.0%
192.37
US$961,850 		5,000 -25.0% 192.37 US$961,850
2023-01-19 2023-01-18 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
200 -0.9%
200.14
US$40,028 		200 -0.9% 200.14 US$40,028
2023-01-19 2023-01-17 PlS Planned sale
3.6
Ignelzi Troy A.

Chief Financial Officer

Officer
817 -3.6%
201.41
US$164,552 		817 -3.6% 201.41 US$164,552
Explore more

More insider trading research around Karuna Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America